Fennec Pharmaceuticals (FENC) Shares Outstanding (2010 - 2026)

Fennec Pharmaceuticals (FENC) has 16 years of Shares Outstanding (Entity) data on file, last reported at $34.2 million in Q4 2025.

• Quarterly Shares Outstanding (Entity) rose 24.11% year-over-year to $34.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $34.2 million (up 24.11% YoY) and the FY2025 annual result came in at $34.2 million, up 24.11% from the prior year.
• Shares Outstanding (Entity) advanced to $34.2 million in Q4 2025, from $28.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $34.2 million in Q4 2025 to a low of $26006.0 in Q4 2021.
• A 5-year average of $25.8 million and a median of $26.6 million in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) tumbled 99.9% — and 2022, when it soared 101265.07%.
• Tracing FENC's Shares Outstanding (Entity) over 5 years: stood at $26006.0 in 2021, then soared by 101265.07% to $26.4 million in 2022, then advanced by 2.53% to $27.0 million in 2023, then grew by 1.85% to $27.5 million in 2024, then increased by 24.11% to $34.2 million in 2025.
• The last three Shares Outstanding (Entity) figures came in at $34.2 million (Q4 2025), $28.1 million (Q3 2025), and $27.7 million (Q2 2025), per Business Quant data.